News
26d
Investor's Business Daily on MSNCatalyst Pharma Battles To All-Time High After Huge Patent Lawsuit WinAnd Catalyst Pharmaceuticals stock is one of those that seems to be thriving. Catalyst is Thursday's selection for IBD 50 Stocks To Watch as it hovers above a buy point of 24.64. Catalyst is ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results